Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
304
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Samsung Electronics
•
24 Jun 2019 15:28
Smartkarma Originals
Samsung Electronics. A Bearish Investment Thesis.
EXECUTIVE SUMMARY We have a negative view of Samsung Electronics over the next one to two years. We believe investors will have an opportunity to...
Douglas Kim
Follow
842 Views
Share
bullish
•
Wuxi Biologics
•
18 Jun 2019 23:07
WuXi Biologics Placement: Attractive in the Context of Market, Financials and Valuation
Wuxi Biologics (Cayman) Inc (2269 HK) is a global one-stop biologics services provider and often referred to as CRO (contract research...
Arun George
Follow
575 Views
Share
bearish
•
Celltrion Healthcare
•
24 Feb 2019 12:05
Celltrion Healthcare: Well, We Were Warned
Celltrion Healthcare (091990 KS) reported preliminary 2018 results that were dramatically short of expectations as the company cut shipments to...
Kemp Dolliver, CFA
543 Views
Share
bullish
•
Samsung C&T
•
15 Jan 2019 14:30
Samsung C&T: A Restructuring of Fashion Business Is Likely After the Stepping Down of Lee Seo-Hyun
Lee Seo-Hyun (age 46), the billionaire second daughter of the Samsung Group Lee Gun-Hee, recently stepped down from her position as the CEO...
Douglas Kim
Follow
575 Views
Share
bearish
•
Wuxi Biologics
•
14 Jan 2019 04:16
WuXi Biologics – The Foxconn or Qualcomm of Global CDMO?
During the first week of 2019, we visited Wuxi Biologics (Cayman) Inc (2269 HK) headquarters in Shanghai, as well as spend time touring the lab....
JL Warren Capital
Follow
850 Views
Share
First
Previous
37
38
39
40
41
42
43
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x